News

Deal Announcements

AqueSys Fills Up With $35 Million Venture Capital

Wednesday, June 30, 2010 5:33:00 AM PDT | VentureDeal Staff
Irvine, California  --  Medical device company AqueSys has secured $35 million in its third round of institutional venture capital investment.

AqueSys is in clinical trials for the development of a device to treat primary open angle glaucoma.

Longitude Capital Management and Rho Ventures led the round, which also included Accuitive Medical Ventures, the Carlyle Group and SV Life Sciences.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1